Andrew Dickinson Insider Trades & Stock Holdings

Chief Financial Officer · Gilead Sciences, Inc. · Latest filing Jun 15, 2026

Andrew Dickinson, Chief Financial Officer at Gilead Sciences, Inc. has 1 Form 4 trade on file since Jun 15, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($376.20K), net -$376.20K. Latest filing: disposed of 3K shares of $GILD on Jun 15, 2026 at $125.40.

Trades on file

1

Open-market bought

$0

Open-market sold

$376.20K

Net open-market

-$376.20K

Latest filing

Jun 15, 2026

All insider trades by Andrew Dickinson

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 15, 2026	$GILD	Sell (Open-market sale) 10b5-1	3K	$125.40	$376.20K			+0.5%	+6.0%		Chief Financial Officer		Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Andrew Dickinson traded

• $GILD

Frequently asked questions

Has Andrew Dickinson been buying or selling stock?

Andrew Dickinson has 0 open-market purchases and 1 open-market sale on file, net -$376.20K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Andrew Dickinson's latest insider trade?

disposed of 3K shares of $GILD on Jun 15, 2026 at $125.40.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.